COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Should CTRs be implanted in every patient with PXE?

August 15, 2006

Article

Cataract surgery in the presence of pseudoexfoliation of the lens (PXE) presents surgeons with many challenges. In addition to a higher incidence of glaucoma, these patients have loss of zonular integrity, occasionally associated with lens subluxation and pupils that dilate poorly.

Most surgeons are currently implanting CTRs only when evidence of zonular instability develops during phacoemulsification. Increasing reports of late IOL/capsular bag subluxation (Figure 2) in patients with PXE^4,5 necessitate reevaluating whether CTRs should be placed on an as-needed basis or implanted in every patient with PXE.